Details
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationRanked by rounds participated in, from announcements in Oct 1, 2026 – Oct 31, 2026. Lead counts include only confirmed lead roles.
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationNew companies 14 · Follow-on 2
Stages: Series B 6, Series A 4, Series C+ 3, Seed 2, Undisclosed 1
Eka Robotics $150M Series ATown $108M Series BLabelbox >$100M Series ENew companies 12 · Follow-on 1
Stages: Series A 6, Seed 3, Series B 2, Series C+ 1, Undisclosed 1
Blacksmith $66M Series CGreptile $50M Series BMolagri Undisclosed SeedNew companies 10 · Follow-on 0
Stages: Undisclosed 8, Series B 2
Riverlane Undisclosed Planned strategic investmentForesight Undisclosed Planned strategic investmentHiverge Undisclosed Planned strategic investmentNew companies 7 · Follow-on 1
Stages: Seed 3, Series C+ 2, Series A 1, Series B 1, Undisclosed 1
Warhound $200M SeedBlacksmith $66M Series CAbby Care $82M Series CNew companies 5 · Follow-on 2
Stages: Undisclosed 3, Series B 2, Series C+ 2
Coast $35M UndisclosedLegora $550M Series ERapidCanvas $29M Series BNew companies 5 · Follow-on 2
Stages: Series A 3, Seed 2, Series B 1, Undisclosed 1
Warp Sciences $215M Series ADifferent $48M SeedZenzap Undisclosed Series A (incremental amount undisclosed)New companies 3 · Follow-on 3
Stages: Seed 2, Series A 2, Series C+ 2, Pre-seed 1
Legora $550M Series EDifferent $48M SeedBaba $40M Series ANew companies 6 · Follow-on 0
Stages: Undisclosed 4, Series A 1, Series B 1
HEARTBEATS, Inc. ¥1.3B Debt financingiCUREX ¥140M Series A first close: equity and debtugo ¥1B Debt financingNew companies 6 · Follow-on 0
Stages: Undisclosed 4, Series A 1, Series C+ 1
Knowledge Work ¥4.8B Series C debt second closeHEARTBEATS, Inc. ¥1.3B Debt financingWHILL Undisclosed Bond-type preferred shares — mezzanineNew companies 5 · Follow-on 1
Stages: Seed 2, Series A 1, Series B 1, Series C+ 1, Undisclosed 1
Maxinsights $30M Seed roundDaytona $60M Series BChariot Claims $10M Series ANew companies 5 · Follow-on 1
Stages: Series A 2, Series B 2, Series C+ 1, Undisclosed 1
Chapter Home ₹630M UndisclosedLegora $550M Series EMach9 $34M Series ANew companies 5 · Follow-on 1
Stages: Series B 4, Series A 1, Series C+ 1
Warp Sciences $215M Series AGreptile $50M Series BTown $108M Series BNew companies 4 · Follow-on 2
Stages: Undisclosed 2, Seed 1, Series A 1, Series B 1, Series C+ 1
Opply $7.5M UndisclosedDuvo $32M Series AAllara $30M FundingNew companies 6 · Follow-on 0
Stages: Series B 3, Undisclosed 2, Series C+ 1
Tolan $30M UndisclosedEven Healthcare $50M Series BAbby Care $82M Series CNew companies 3 · Follow-on 2
Stages: Series C+ 2, Series A 1, Series B 1, Undisclosed 1
Blacksmith $66M Series CEstuary Biotherapeutics $93M Series AOMass Therapeutics $310M Series CNew companies 4 · Follow-on 0
Stages: Seed 1, Series A 1, Series B 1, Series C+ 1
Warp Sciences $215M Series AWarhound $200M SeedModal Labs $750M Series DNew companies 4 · Follow-on 0
Stages: Pre-seed 3, Seed 1
Jenz €540K Pre-seedAffinity Labs $2M Pre-seed funding including grantCodeWall $4M Pre-seedNew companies 3 · Follow-on 1
Stages: Series C+ 2, Series B 1, Undisclosed 1
Legora $550M Series ETenstorrent $1.5B Series ESoufflé Therapeutics $135M Series BNew companies 3 · Follow-on 1
Stages: Series A 2, Seed 1, Series B 1
Mach9 $34M Series ATown $108M Series BHealthleap $8M SeedNew companies 4 · Follow-on 0
Stages: Undisclosed 2, Pre-seed 1, Seed 1
Emerald £1.4M Grant and venture fundingGo Eve Undisclosed UndisclosedAffinity Labs $2M Pre-seed funding including grantNew companies 4 · Follow-on 0
Stages: Series A 2, Series B 1, Series C+ 1
Nouscom €120M Series DCarbonFarm €7M Series AEdonia €15M Series A financing package including non-dilutive and bank fundingNew companies 4 · Follow-on 0
Stages: Seed 2, Series A 2
Chariot Claims $10M Series AGoodweek $12M SeedCausa Prima $20M SeedNew companies 4 · Follow-on 0
Stages: Seed 2, Undisclosed 2
Tab Undisclosed UndisclosedSafeWorld $12.2M SeedGhost $11M SeedNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Series C+ 1
Knowledge Work ¥4.8B Series C debt second closeHEARTBEATS, Inc. ¥1.3B Debt financingugo ¥1B Debt financingNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Series C+ 1
Knowledge Work ¥4.8B Series C debt second closeNEXTES ¥2B Syndicated term loanHenry ¥1.2B Venture debt and equityNew companies 2 · Follow-on 1
Stages: Seed 1, Series B 1, Series C+ 1
Warhound $200M SeedSirona Medical $40M Series DArmadin $255.5M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Series A 1
CureBay ~₹1B Pre-Series CMesa School of Business ₹1.1B Series A and venture debtLorazzo ₹150M Funding roundNew companies 2 · Follow-on 1
Stages: Undisclosed 2, Series C+ 1
CureBay ~₹1B Pre-Series CScimplify $25M Strategic financingNat Habit ₹1.4B Series CNew companies 3 · Follow-on 0
Stages: Seed 1, Series C+ 1, Undisclosed 1
Warhound $200M SeedWaymo $5B Term loanDevoted Health $555M Series G“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.